Are you Dr. Karas?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 56 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
750 Washington St
Boston, MA 02111Phone+1 617-636-5000Fax+1 617-636-6204
Summary
- Dr. Richard Karas, MD is a cardiologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Tufts Medical Center and is a Professor at Tufts Medical Center.
Education & Training
- Duke University HospitalFellowship, Cardiovascular Disease, 1989 - 1990
- Brigham and Women's HospitalResidency, Internal Medicine, 1986 - 1989
- Tufts University School of MedicineClass of 1986
Certifications & Licensure
- MA State Medical License 1989 - 2016
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 22 citationsPeripheral arterial tonometry for risk stratification in men with coronary artery disease.Kevin S. Heffernan, Richard H. Karas, Eshan Patvardhan, Haseeb Jafri, Jeffrey T. Kuvin
Clinical Cardiology. 2010-02-01 - 54 citationsRapid Estrogen Receptor Signaling Mediates Estrogen-Induced Inhibition of Vascular Smooth Muscle Cell ProliferationKazutaka Ueda, Qing Lu, Wendy Baur, Mark Aronovitz, Richard H. Karas
Arteriosclerosis, Thrombosis, and Vascular Biology. 2013-08-01 - 129 citationsThe Current State of Niacin in Cardiovascular Disease Prevention: A Systematic Review and Meta-RegressionPaul M. Lavigne, Richard H. Karas
Journal of the American College of Cardiology. 2013-01-29
Press Mentions
- Abiomed Übernimmt preCARDIA, Ein Bahnbrechendes Medizintechnikunternehmen, Um Die Behandlungsergebnisse Von Patienten Mit Herzinsuffizienz Zu VerbessernJune 1st, 2021
- Abiomed Acquires preCARDIA, a Breakthrough Medical Device Company, to Improve Outcomes for Heart Failure PatientsJune 1st, 2021
- Muscle Damage from Statins May Evade Blood TestSeptember 11th, 2013